NIH Trial Halts After Smallpox Drug Fails to Show Benefit for Mpox
A clinical trial testing a smallpox antiviral for mpox was halted after interim findings showed no efficacy in reducing lesion resolution or pain in mild to moderate cases.
A clinical trial testing a smallpox antiviral for mpox was halted after interim findings showed no efficacy in reducing lesion resolution or pain in mild to moderate cases.
A clinical trial testing a smallpox antiviral for mpox was halted after interim findings showed no efficacy in reducing lesion resolution or pain in mild to moderate cases.
Read MoreThe WHO has granted Emergency Use Listing for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO and the first for children over age 1.
Read MoreThe California Department of Public Health confirmed through laboratory testing the first known case of clade I mpox in the United States.
Read MoreThe World Health Organization has granted Emergency Use Listing to a rapid PCR-based mpox test, enhancing access to point-of-care diagnostics.
Read MoreThe NIH clinical trial aims to address a knowledge gap on mpox vaccine use in adolescent populations.
Read MoreMinimally-invasive blood collection devices could increase the participation of people experiencing homelessness (PEH) in public health studies and clinical research.
Read MoreUsing gene editing proteins combined with nanopore sensing technology, new research shows that testing for pathogens could become faster and more accessible.
Read MoreAuthorized to be used in professional point-of-care settings, the nucleic acid amplification test can detect mpox virus and deliver results in 25 minutes.
Read MoreThe CDC has activated its Emergency Operations Center for monitoring and coordinating the emergency response to monkeypox.
Read MoreMonkeypox can be transmitted via respiratory droplets, but it is not an aerosolized or airborne transmission disease, according to a “Fact Check” published recently by Reuters Health.
Read MoreThe CDC has reported a case of monkeypox discovered in Maryland. The case was reported in a US traveler returning to the US from Nigeria, according to the agency.
Read MoreThe CDC is monitoring more than 200 people for potential exposure to monkeypox after an individual who contracted the disease in Nigeria arrived at a Texas airport.
Read MoreThe CDC is looking into a case of an unusual virus called monkeypox in a traveler coming from Nigeria, according to a report from CNN Health.
Read MoreThe monkeypox virus increased production of proteins involved in inflammation while decreasing production of proteins that keep lung tissue intact and lubricated.
Read More